EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 20-Dec-2025 13:11 ET (20-Dec-2025 18:11 GMT/UTC)

21-Aug-2025

How AI will transform mental health support for patients with breast cancer

University of Virginia Health System
Peer-Reviewed Publication

From virtual counselors that can hear depression creeping into a person’s voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients with breast cancer.

Journal: AI in Precision Oncology

21-Aug-2025

Cumulative hepatitis B surface antigen/hepatitis B virus DNA ratio in immune-tolerant hepatitis B patients

Xia & He Publishing Inc.
Peer-Reviewed Publication

Patients with chronic hepatitis B virus (HBV) infection in the immune-tolerant phase may still experience hepatic inflammation and disease progression, and could benefit from early antiviral treatment. This study aimed to investigate changes in the cumulative hepatitis B surface antigen (HBsAg)/HBV DNA ratio in immune-tolerant patients during the transition to the immune-active phase, and to evaluate its potential in predicting the risk of disease progression.

Journal: Journal of Clinical and Translational Hepatology

21-Aug-2025

Nation’s leading breast health advocate receives Benjamin Spock Award for Compassion in Medicine

Physicians Committee for Responsible Medicine
Grant and Award Announcement

Santa Monica Breast Surgeon and Founder of the Pink Lotus Breast Center Kristi Funk, MD, FACS, received the Benjamin Spock Award for Compassion in Medicine at the International Conference on Nutrition and Medicine (ICNM) on Aug. 15. The award was presented by Neal Barnard, MD, president of the Physicians Committee for Responsible Medicine, a public health advocacy nonprofit with more than 17,000 doctor members.

21-Aug-2025

Beijing Tiantan Hospital researchers pioneer one-stage hybrid surgery for brain and spine tumors

Chinese Neurosurgical Journal
Peer-Reviewed Publication

Researchers at Beijing Tiantan Hospital have developed a one-stage hybrid approach that combines embolization and microsurgical removal of hypervascular central nervous system (CNS) tumors in a single operation. In a decade-long study of 31 patients, this innovative method reduced blood loss, avoided embolization-related complications, and preserved neurological function. Published in the Chinese Neurosurgical Journal, the findings suggest a safer alternative to traditional staged surgeries for treating high-risk brain and spinal tumors.

Journal: Chinese Neurosurgical Journal
Funder: National Key Technologies R&D Program of China, National Key Technologies R&D Program of China, Dengfeng Talent Training Program of Beijing Hospital Management Center

21-Aug-2025

New tracer could enable surgeons to see and hear prostate cancer

University of British Columbia
Peer-Reviewed Publication

A preclinical evaluation of a new ’dual-mode’ tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery.

Journal: Journal of Medicinal Chemistry
Funder: Canadian Institutes of Health Research

21-Aug-2025

New research identifies key genes that act as a brake on blood cancer growth

La Trobe University
Peer-Reviewed Publication

Australian researchers have used an innovative genome-wide screening approach to identify genes, and their encoded proteins, that play critical roles in the prevention of lymphoma development, revealing new potential treatment targets for these blood cancers.

Journal: Nature Communications

21-Aug-2025

Repackaged cancer drug boosts delivery to tumors, improves combination therapies

University of Arizona, Office of Research and Partnerships
Peer-Reviewed Publication

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than standard forms of chemotherapy. They repackaged the drug paclitaxel, creating a new formulation that may help overcome some common limitations of chemotherapy drugs, including toxicity, setting the stage for a promising new platform for treating cancer and other diseases.

Journal: Nature Cancer
Funder: NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences

21-Aug-2025

Peking University scientists develop universal “off-the-shelf” cancer therapy

Peking University
Peer-Reviewed Publication

Peking University, September 8, 2025: Peking University scientists have developed a groundbreaking cancer therapy that could make life-saving treatment accessible to any patient, anywhere. A team led by Professor Wei Wensheng from Peking University, collaborating with the PLA General Hospital and biotech company EdiGene Inc., has developed a novel cancer therapy that could make advanced treatment accessible to many more patients. Their study was published in Cell on August 21, 2025.

Journal: Cell

20-Aug-2025

New study maps out the timeline of DNA damage for multiple myeloma

University of Miami Miller School of Medicine
Peer-Reviewed Publication

A new study published in the journal Nature Genetics maps out the timeline of DNA damage for multiple myeloma. The findings may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict treatment strategies and outcomes.

Journal: Nature Genetics

20-Aug-2025

Study advances understanding of rare type of lung cancer

University of Oklahoma
Peer-Reviewed Publication

OKLAHOMA CITY – Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature Communications provides a new understanding of the disease and uncovers a potential target for treatment.

Journal: Nature Communications